Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of Nutrition and Food Security. 2017; 2 (2): 179-184
in English | IMEMR | ID: emr-194903

ABSTRACT

Background: In acute lymphoblastic leukemia [ALL] the bone marrow loses its ability in the differentiation and maturation of blood cells at different stages. Zinc and copper are important co-factors for several enzymes and play an important role in maintenance of DNA integrity. Changes in serum levels of zinc and copper have been found in lymphoproliferative disorders. In the present study, the aim was to compare serum levels of zinc, copper, vitamin D, and inflammatory markers after eight courses of chemotherapy


Methods: Participants of this study included 30 ALL patients in the age range of 15 to 65 years. A 10 mL blood sample was taken before and after eight courses of chemotherapy. The concentration of Zinc, Copper, hs-CRP, vitamin D and malondialdehyde [MDA] were measured


Results: There was a significant increase in serum zinc [121.7 +/- 18.05 microg/dL before chemotherapy and 156.6 +/- 25.00 microg/dL after chemotherapy] and a significant decrease in serum copper [661.9 +/- 190.1 microg/dL before chemotherapy and 402.2 +/- 93.5 microg/dL after chemotherapy] and a significant decrease in Malondialdehyde and serum vitamin D were observwd. Further, no significant differences were observed in hs-CRP after chemotherapy


Conclusion: Results showed that chemotherapy could decrease the burden of disease by increasing serum zinc and decreasing serum copper

SELECTION OF CITATIONS
SEARCH DETAIL